| Literature DB >> 33164988 |
Mathieu Favier1,2, Helena Janickova2, Damian Justo3, Ornela Kljakic2, Léonie Runtz1, Joman Y Natsheh4,5, Tharick A Pascoal1, Jurgen Germann6, Daniel Gallino6, Jun-Ii Kang1, Xiang Qi Meng1, Christina Antinora1, Sanda Raulic2, Jacob Pr Jacobsen7, Luc Moquin1, Erika Vigneault1, Alain Gratton1, Marc G Caron7,8,9, Philibert Duriez3, Mark P Brandon1, Pedro Rosa Neto1, M Mallar Chakravarty6,10,11, Mohammad M Herzallah4,12, Philip Gorwood3, Marco Am Prado2, Vania F Prado2, Salah El Mestikawy1,13.
Abstract
Dysregulation of habit formation has been recently proposed as pivotal to eating disorders. Here, we report that a subset of patients suffering from restrictive anorexia nervosa have enhanced habit formation compared with healthy controls. Habit formation is modulated by striatal cholinergic interneurons. These interneurons express vesicular transporters for acetylcholine (VAChT) and glutamate (VGLUT3) and use acetylcholine/glutamate cotransmission to regulate striatal functions. Using mice with genetically silenced VAChT (VAChT conditional KO, VAChTcKO) or VGLUT3 (VGLUT3cKO), we investigated the roles that acetylcholine and glutamate released by cholinergic interneurons play in habit formation and maladaptive eating. Silencing glutamate favored goal-directed behaviors and had no impact on eating behavior. In contrast, VAChTcKO mice were more prone to habits and maladaptive eating. Specific deletion of VAChT in the dorsomedial striatum of adult mice was sufficient to phenocopy maladaptive eating behaviors of VAChTcKO mice. Interestingly, VAChTcKO mice had reduced dopamine release in the dorsomedial striatum but not in the dorsolateral striatum. The dysfunctional eating behavior of VAChTcKO mice was alleviated by donepezil and by l-DOPA, confirming an acetylcholine/dopamine deficit. Our study reveals that loss of acetylcholine leads to a dopamine imbalance in striatal compartments, thereby promoting habits and vulnerability to maladaptive eating in mice.Entities:
Keywords: Mouse models; Neuroscience; Psychiatric diseases
Year: 2020 PMID: 33164988 PMCID: PMC7685731 DOI: 10.1172/JCI138532
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808